MEK162 in Combination With Capecitabine in Advanced Biliary Tract Cancer
Clinical trial NCT02773459 · COMPLETED
Trial details
- NCT number
- NCT02773459
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2019-01-07
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.